Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study

BMC Nephrology

Table 4 Body composition data divided in three groups according to the assigned intervention

Variables	Exercise group	Dopamine agonists group	Placebo group
DEXA-derived data
Total Body Fat (%)
Baseline	30.9±9.0	31.9±11.2	26.0±5.4
6-m post	30.5±8.1	27.1±7.5	28.5±5.8
Δ Change	- 0.38±1.83	- 4.71±10.86	2.45±2.24
95% CI of Δ change	−1.39 to 0.63	−14.70 to 5.32	4.50 to 0.38
% Legs Fat
Baseline	32.7±10.2	29.9±13.2	26.2±4.9
6-m post	32.3±9.3	25.1±8.9	28.5±5.2
Δ Change	- 0.37±2.71	- 4.86±11.03	2.27±6.50
95% CI of Δ change	−1.86 to 1.12	−15.05 to 5.28	8.27 to −3.73
Total LBM (Kg)
Baseline	45.3±7.8	47.7±5.4	46.1±5.0
6-m post	46.7±8.3†	49.8±3.4	45.4±5.1
Δ Change	1.38±1.23	2.12±4.85	- 0.66±0.71
95% CI of Δ change	2.06 to 0.70	6.61 to −2.37	−1.31 to −0.01